Altius Direct Electrical Nerve Stimulation System
Neuros Medical, Inc. · Decision date Dec 3, 2025
What did the FDA approve?
FDA records P230020/S005 as a supplement to PMA P230020, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Dec 3, 2025.
FDA approval order statement
approval for a manufacturing site located at Neuros Medical, Inc., 1212 Red Fox Road, Arden Hills, Minnesota, 55112. The main manufacturing operations performed at this facility include, but are not limited to, the receipt of sterile and non-sterile finished packaged devices ready for distribution from two contract manufacturing organization facilities, evaluation of returned devices, calibration and maintenance of inspection equipment, and serve as the specification developer and design control center.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Neurology
- Decision date
- Dec 3, 2025
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P230020/S005
- Regulatory pathway
- PMA supplement
- Applicant
- Neuros Medical, Inc.
- Product code
- SAZ
- Decision code
- APPR
- Decision date
- Dec 3, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: stimulator, nerve terminus, totally implanted for chronic intractable post-amputation pain of the lower limb.
- Applicant
- Neuros Medical, Inc.
- Product code
- SAZ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P230020. Subsequent supplements may change the device or its indications.
FDA decision timeline
P230020 · Original PMA
Altius Direct Electrical Nerve Stimulation System
P230020/S005 received
Application receipt date recorded by FDA.
P230020/S005 · FDA decision
Normal 180 Day Track No User Fee
P230020/S007 · Related supplement
Altius Direct Electrical Nerve Stimulation System
P230020/S006 · Related supplement
Altius Direct Electrical Nerve Stimulation System
P230020/S011 · Related supplement
Altius Direct Electrical Nerve Stimulation System
Timeline entries are records held by MedtechLedger for P230020. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230020
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Neuros Medical, Inc. | PMA approval | Aug 26, 2024 | FDA | |
| Neuros Medical, Inc. | PMA supplement | Feb 28, 2026 | FDA | |
| Neuros Medical, Inc. | PMA supplement | May 5, 2026 | FDA | |
| Neuros Medical, Inc. | PMA supplement | Oct 16, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Neuros Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 26800 Aliso Viejo Pkwy., Suite 250, Aliso Viejo, CA, 92656
Sources and methodology
- Original FDA record: P230020/S005
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


